Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher J Ricketts

Showing results (51-60 of 101) with videos related to

Pageof 11
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 22, 2020
Growth Rates of Genetically Defined Renal Tumors: Implications for Active Surveillance and InterventionMark W Ball, Julie Y An, Patrick T Gomella, et al.
Nature Cell Biology|June 11, 2026
TEAD1 condensates are transcriptionally inactive storage sites on the pericentromeric heterochromatin in cancer cellsYiran Wang, Jindayi Liang, Kimberly S Lange, et al.
Clinical Genitourinary Cancer|August 29, 2025
Is Active Surveillance a Suitable Approach for Bilateral Multifocal Renal Oncocytomas? The 20-Year National Cancer Institute ExperienceAditi Chaurasia, Shiva Singh, Noah Pinson, et al.
Journal of Experimental & Clinical Cancer Research : CR|June 26, 2022
Inhibition of HSP 90 is associated with potent anti-tumor activity in Papillary Renal Cell CarcinomaRoma Pahwa, Janhavi Dubhashi, Anand Singh, et al.
Human Mutation|September 4, 2013
UBE2QL1 is disrupted by a constitutional translocation associated with renal tumor predisposition and is a novel candidate renal tumor suppressor geneNaomi C Wake, Christopher J Ricketts, Mark R Morris, et al.
Urology|November 20, 2018
CDC73 Germline Mutation in a Family With Mixed Epithelial and Stromal TumorsCathy D Vocke, Christopher J Ricketts, Mark W Ball, et al.
Endocrine-Related Cancer|October 21, 2010
Mutation analysis of HIF prolyl hydroxylases (PHD/EGLN) in individuals with features of phaeochromocytoma and renal cell carcinoma susceptibilityDewi Astuti, Christopher J Ricketts, Rasheduzzaman Chowdhury, et al.
Scientific Reports|December 6, 2019
Proteasome inhibition disrupts the metabolism of fumarate hydratase- deficient tumors by downregulating p62 and c-MycCarole Sourbier, Christopher J Ricketts, Pei-Jyun Liao, et al.
Anticancer Research|December 25, 2009
Mutation analysis of hypoxia-inducible factors HIF1A and HIF2A in renal cell carcinomaMark R Morris, David J Hughes, Ya-Min Tian, et al.
Blood|August 14, 2020
Glycolytic metabolism of pathogenic T cells enables early detection of GVHD by 13C-MRIJulian C Assmann, Don E Farthing, Keita Saito, et al.
Pageof 11

Showing results (51-60 of 101) with videos related to

Sort By:
Pageof 11
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 22, 2020
Growth Rates of Genetically Defined Renal Tumors: Implications for Active Surveillance and InterventionMark W Ball, Julie Y An, Patrick T Gomella, et al.
Nature Cell Biology|June 11, 2026
TEAD1 condensates are transcriptionally inactive storage sites on the pericentromeric heterochromatin in cancer cellsYiran Wang, Jindayi Liang, Kimberly S Lange, et al.
Clinical Genitourinary Cancer|August 29, 2025
Is Active Surveillance a Suitable Approach for Bilateral Multifocal Renal Oncocytomas? The 20-Year National Cancer Institute ExperienceAditi Chaurasia, Shiva Singh, Noah Pinson, et al.
Journal of Experimental & Clinical Cancer Research : CR|June 26, 2022
Inhibition of HSP 90 is associated with potent anti-tumor activity in Papillary Renal Cell CarcinomaRoma Pahwa, Janhavi Dubhashi, Anand Singh, et al.
Human Mutation|September 4, 2013
UBE2QL1 is disrupted by a constitutional translocation associated with renal tumor predisposition and is a novel candidate renal tumor suppressor geneNaomi C Wake, Christopher J Ricketts, Mark R Morris, et al.
Urology|November 20, 2018
CDC73 Germline Mutation in a Family With Mixed Epithelial and Stromal TumorsCathy D Vocke, Christopher J Ricketts, Mark W Ball, et al.
Endocrine-Related Cancer|October 21, 2010
Mutation analysis of HIF prolyl hydroxylases (PHD/EGLN) in individuals with features of phaeochromocytoma and renal cell carcinoma susceptibilityDewi Astuti, Christopher J Ricketts, Rasheduzzaman Chowdhury, et al.
Scientific Reports|December 6, 2019
Proteasome inhibition disrupts the metabolism of fumarate hydratase- deficient tumors by downregulating p62 and c-MycCarole Sourbier, Christopher J Ricketts, Pei-Jyun Liao, et al.
Anticancer Research|December 25, 2009
Mutation analysis of hypoxia-inducible factors HIF1A and HIF2A in renal cell carcinomaMark R Morris, David J Hughes, Ya-Min Tian, et al.
Blood|August 14, 2020
Glycolytic metabolism of pathogenic T cells enables early detection of GVHD by 13C-MRIJulian C Assmann, Don E Farthing, Keita Saito, et al.
Pageof 11